LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Benign Prostatic Hypertrophy Implants Market Snapshot

Published July 2024 | 10 Pages | 4 Exhibits | Forecasts Through 2028

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This market snapshot from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. 

This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:

  • Unit volumes from 2023 to 2028
  • Market forecasts from 2023 to 2028
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Butterly Medical

Endotherapeutics

Olympus

ProArc

ProVerum

Teleflex

ZenFlow

Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.